PubMed Health⌕ Search

PubMed · 13608301

Tranquilizing agents; some problems in evaluating them.

Abstract

Evaluation of tranquilizing drugs is more difficult by any technique than evaluation of drugs given for purely organic effect, since both the symptom and its evidences are conditioned by profound psychic values. Difficult as it is to match psychiatric patients as controls, it is equally difficult to use each patient as his own control, since his reaction either to drug or to placebo may be strongly affected by previous experience with the other dose or with other drugs. In a "double blind, double cross" test comparing the values of prochlorperazine and phenobarbital, the controller misled the observers by maintaining the same drug for each patient during the entire test period. The observers detected that the test was not going according to plan, and when the "double cross" was revealed they were able to guess fairly well which patients had received each drug. The experiment not only sharpened their future observation, but demonstrated the reliability of trained clinical judgment in evaluating drugs when bias is eliminated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S COHEN. 1958. Tranquilizing agents; some problems in evaluating them.. https://pubmed.ncbi.nlm.nih.gov/13608301/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Oxygen-saturation targets and outcomes in extremely preterm infants.

BACKGROUND: Physiological studies have shown that chronic hypoxemia may occur in preterm infants who require supplemental oxygen for extended periods and that this hypoxemia may contribute to poor growth and development. Anecdotal reports and uncontrolled observational studies have suggested that a higher oxygen-saturation range may be beneficial in terms of growth and development. METHODS: We conducted a multicenter, double-blind, randomized, controlled trial involving 358 infants born at less than 30 weeks of gestation who remained dependent on supplemental oxygen at 32 weeks of postmenstrual age. They were randomly assigned to a target functional oxygen-saturation range of either 91 to 94 percent (standard-saturation group) or 95 to 98 percent (high-saturation group); this target was maintained for the duration of supplemental-oxygen therapy. The primary outcomes were growth and neurodevelopmental measures at a corrected age of 12 months. RESULTS: There were no significant differences between the groups in weight, length, or head circumference at a corrected age of 12 months. The frequency of major developmental abnormalities also did not differ significantly between the standard-saturation group and the high-saturation group (24 percent and 23 percent, respectively, P=0.85). There were six deaths due to pulmonary causes in the high-saturation group and one such death in the standard-saturation group (P=0.12). The high-saturation group received oxygen for a longer period after randomization (median, 40 days vs. 18 days; P<0.001) and had a significantly higher rate of dependence on supplemental oxygen at 36 weeks of postmenstrual age and a significantly higher frequency of home-based oxygen therapy. CONCLUSIONS: Targeting a higher oxygen-saturation range in extremely preterm infants who were dependent on supplemental oxygen conferred no significant benefit with respect to growth and development and resulted in an increased burden on health services.

Double-Blind Method↗